ALLIANCEBERNSTEIN L.P. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 29 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q1 2014$1,0000.0%2070.0%0.00%
Q4 2013$1,0000.0%2070.0%0.00%
Q3 2013$1,0002070.00%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2013
NameSharesValueWeighting ↓
MARATHON CAPITAL MANAGEMENT 41,650$253,0000.18%
Eidelman Virant Capital 27,796$169,0000.07%
WMS Partners, LLC 63,350$384,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 62,742$381,0000.05%
Brown Advisory Securities, LLC 10,000$61,0000.02%
CROFT-LEOMINSTER INC 20,000$121,0000.02%
GSA CAPITAL PARTNERS LLP 15,479$94,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$152,0000.01%
CANADA PENSION PLAN INVESTMENT BOARD 120,913$734,0000.00%
Virtu KCG Holdings LLC 23,325$140,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders